Wells Fargo & Company Codex Dna, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	N/A	1 Added 1.45%	70 $0
Q4 2023 Feb 09, 2024	BUY	N/A	3 Added 4.55%	69 $0
Q3 2023 Nov 13, 2023	BUY	N/A	2 Added 3.13%	66 $0
Q2 2023 Aug 15, 2023	BUY	N/A	3 Added 4.92%	64 $0
Q1 2023 May 12, 2023	BUY	$1.3 - $2.15 $1 - $2	1 Added 1.67%	61 $0
Q4 2022 Feb 13, 2023	BUY	$1.12 - $1.69 $1 - $1	1 Added 1.69%	60 $0
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.36 $20 - $28	12 Added 25.53%	59 $0
Q2 2022 Aug 12, 2022	SELL	$1.8 - $6.45 $3,258 - $11,674	-1,810 Reduced 97.47%	47 $0
Q1 2022 May 16, 2022	SELL	$4.12 - $10.36 $7,205 - $18,119	-1,749 Reduced 48.5%	1,857 $10,000
Q4 2021 Feb 14, 2022	BUY	$6.31 - $11.96 $21,062 - $39,922	3,338 Added 1245.52%	3,606 $39,000
Q3 2021 Nov 15, 2021	BUY	$10.15 - $19.88 $2,720 - $5,327	268 New	268 $3,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.